Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

926 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Seven days triple therapy for eradication of Helicobacter pylori does not alter the disease activity of patients with inflammatory bowel disease.
Shinzaki S, Fujii T, Bamba S, Ogawa M, Kobayashi T, Oshita M, Tanaka H, Ozeki K, Takahashi S, Kitamoto H, Kani K, Nanjo S, Sugaya T, Sakakibara Y, Inokuchi T, Kakimoto K, Yamada A, Yasuhara H, Yokoyama Y, Yoshino T, Matsui A, Nakamura M, Tomizawa T, Sakemi R, Kamata N, Hibi T. Shinzaki S, et al. Among authors: sakakibara y. Intest Res. 2018 Oct;16(4):609-618. doi: 10.5217/ir.2018.00044. Epub 2018 Oct 10. Intest Res. 2018. PMID: 30301329 Free PMC article.
Elderly onset age is associated with low efficacy of first anti-tumor necrosis factor treatment in patients with inflammatory bowel disease.
Amano T, Shinzaki S, Asakura A, Tashiro T, Tani M, Otake Y, Yoshihara T, Iwatani S, Yamada T, Sakakibara Y, Osugi N, Ishii S, Egawa S, Araki M, Arimoto Y, Nakahara M, Murayama Y, Kobayashi I, Kinoshita K, Ogawa H, Hiyama S, Shibukawa N, Komori M, Okuda Y, Kizu T, Yoshii S, Tsujii Y, Hayashi Y, Inoue T, Iijima H, Takehara T. Amano T, et al. Among authors: sakakibara y. Sci Rep. 2022 Mar 29;12(1):5324. doi: 10.1038/s41598-022-09455-8. Sci Rep. 2022. PMID: 35351986 Free PMC article.
Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal adenocarcinoma.
Amano T, Iijima H, Shinzaki S, Tashiro T, Iwatani S, Tani M, Otake Y, Yoshihara T, Sugimoto A, Egawa S, Yamaguchi S, Kinoshita K, Araki M, Hirao M, Sakakibara Y, Hiyama S, Ogawa H, Nagaike K, Murata J, Komori M, Okuda Y, Kizu T, Tsujii Y, Hayashi Y, Inoue T, Takahashi H, Mizushima T, Morii E, Takehara T. Amano T, et al. Among authors: sakakibara y. BMC Cancer. 2021 Aug 31;21(1):978. doi: 10.1186/s12885-021-08724-5. BMC Cancer. 2021. PMID: 34465291 Free PMC article.
Administration of low-dose epoetin-alpha facilitates adherence to ribavirin in triple therapy with pegylated interferon-alpha-2b and telaprevir.
Ishida H, Sakane S, Toyama T, Fukutomi K, Kimura K, Sugimoto A, Hibino K, Tamura T, Iwasaki T, Iwasaki R, Hasegawa H, Sakakibara Y, Yamada T, Nakazuru S, Mita E. Ishida H, et al. Among authors: sakakibara y. Hepatol Res. 2014 Oct;44(10):E84-91. doi: 10.1111/hepr.12224. Epub 2014 Jan 7. Hepatol Res. 2014. PMID: 23957840
A case of Behçet's disease with esophageal ulcers.
Sakakibara Y, Nakazuru S, Akasaka T, Ishida H, Mita E. Sakakibara Y, et al. Gastrointest Endosc. 2019 Feb;89(2):430-431. doi: 10.1016/j.gie.2018.10.015. Epub 2018 Oct 22. Gastrointest Endosc. 2019. PMID: 30359571 No abstract available.
926 results